Lazard Asset Management
EHC icon

Lazard Asset Management’s Encompass Health EHC Stock Holding History

Lazard Asset Management’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.55M Buy
98,693
+25,335
+35% +$2.6M 0.02% 431
2025
Q4 		$7.79M Sell
73,358
-650
-0.9% -$75.3K 0.01% 460
2025
Q3 		$9.4M Sell
74,008
-90,717
-55% -$10.8M 0.01% 439
2025
Q2 		$20.2M Buy
164,725
+5,842
+4% +$667K 0.03% 408
2025
Q1 		$16.1M Buy
158,883
+39,460
+33% +$3.85M 0.02% 395
2024
Q4 		$11M Buy
119,423
+79,046
+196% +$7.76M 0.02% 450
2024
Q3 		$3.9M Buy
40,377
+2,864
+8% +$257K 0.01% 699
2024
Q2 		$3.22M Buy
37,513
+26,599
+244% +$2.23M ﹤0.01% 778
2024
Q1 		$900K Buy
10,914
+1,676
+18% +$123K ﹤0.01% 940
2023
Q4 		$615K Buy
9,238
+12
+0.1% +$777 ﹤0.01% 1061
2023
Q3 		$619K Buy
9,226
+4,869
+112% +$335K ﹤0.01% 1089
2023
Q2 		$294K Buy
4,357
+2,987
+218% +$187K ﹤0.01% 1241
2023
Q1 		$74K Buy
1,370
+80
+6% +$4.66K ﹤0.01% 1645
2022
Q4 		$77K Buy
1,290
+161
+14% +$8.76K ﹤0.01% 1620
2022
Q3 		$51K Sell
1,129
-1,760
-61% -$88K ﹤0.01% 1787
2022
Q2 		$128K Buy
2,889
+2,776
+2,457% +$142K ﹤0.01% 1415
2022
Q1 		$6K Buy
+113
New +$5.9K ﹤0.01% 2168
2020
Q4 		– Sell
-31,312
Closed -$1.62M – 1874
2020
Q3 		$1.62M Sell
31,312
-106,689
-77% -$5.47M ﹤0.01% 750
2020
Q2 		$6.8M Buy
138,001
+21,031
+18% +$1.13M 0.01% 525
2020
Q1 		$5.96M Sell
116,970
-357,917
-75% -$20.6M 0.01% 520
2019
Q4 		$26.2M Buy
474,887
+43,838
+10% +$2.38M 0.04% 301
2019
Q3 		$21.7M Buy
431,049
+235,479
+120% +$11.8M 0.04% 329
2019
Q2 		$9.86M Buy
195,570
+85,467
+78% +$4.15M 0.02% 466
2019
Q1 		$5.11M Sell
110,103
-98,277
-47% -$4.98M 0.01% 585
2018
Q4 		$10.2M Buy
208,380
+4,683
+2% +$266K 0.02% 390
2018
Q3 		$12.6M Buy
203,697
+116,807
+134% +$7.1M 0.02% 384
2018
Q2 		$4.68M Buy
+86,890
New +$4.34M 0.01% 573
2017
Q1 		– Sell
-298
Closed -$9K – 1029
2016
Q4 		$9K Hold
298
– – ﹤0.01% 943
2016
Q3 		$9K Sell
298
-26
-8% -$842 ﹤0.01% 927
2016
Q2 		$10K Sell
324
-114,343
-100% -$3.58M ﹤0.01% 960
2016
Q1 		$3.43M Sell
114,667
-413,389
-78% -$11.4M 0.01% 541
2015
Q4 		$14.6M Buy
528,056
+192,176
+57% +$5.47M 0.03% 301
2015
Q3 		$10.3M Buy
335,880
+16,848
+5% +$587K 0.02% 366
2015
Q2 		$11.7M Buy
319,032
+143,702
+82% +$5.12M 0.02% 351
2015
Q1 		$6.19M Buy
175,330
+167,926
+2,268% +$5.75M 0.01% 496
2014
Q4 		$226K Hold
7,404
– – ﹤0.01% 903
2014
Q3 		$217K Buy
7,404
+523
+8% +$15.9K ﹤0.01% 832
2014
Q2 		$196K Buy
+6,881
New +$192K ﹤0.01% 862

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Lazard Asset Management's EHC Position: Q1 2026 in Review

Lazard Asset Management increased its Encompass Health (EHC) stake by 35% in Q1 2026, buying an estimated $2.6M and bringing the position to 98,693 shares worth $9.55M. The position accounts for 0.02% of the portfolio, ranked #431.

Lazard Asset Management first reported a position in EHC in Q2 2014 and has held it in 38 quarters since. The position peaked at $26.2M in Q4 2019. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Lazard Asset Management held 98,693 shares of Encompass Health worth $9.55M as of Q1 2026.
  • Lazard Asset Management bought 25,335 Encompass Health shares in Q1 2026, an estimated $2.6M.
  • Encompass Health made up 0.02% of Lazard Asset Management's portfolio in Q1 2026, its #431 holding.
  • Lazard Asset Management first reported a position in Encompass Health in Q2 2014 and has held it in 38 quarters since.
  • Lazard Asset Management's Encompass Health position peaked at $26.2M in Q4 2019.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.